BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24513359)

  • 1. Quantitative echography in primary uveal melanoma treated by proton beam therapy.
    Mosci C; Lanza FB; Mosci S; Barla A
    Can J Ophthalmol; 2014 Feb; 49(1):60-5. PubMed ID: 24513359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in ultrasound findings in posterior uveal melanoma after Ruthenium 106 brachytherapy.
    Kaiserman I; Anteby I; Chowers I; Blumenthal EZ; Kliers I; Pe'er J
    Ophthalmology; 2002 Jun; 109(6):1137-41. PubMed ID: 12045056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
    Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
    Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up.
    Foti PV; Longo A; Reibaldi M; Russo A; Privitera G; Spatola C; Raffaele L; Salamone V; Farina R; Palmucci S; Musumeci A; Caltabiano R; Ragusa M; Mariotti C; Avitabile T; Milone P; Ettorre GC
    Radiol Med; 2017 Feb; 122(2):131-139. PubMed ID: 27752969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour Response in Uveal Melanomas Treated with Proton Beam Therapy.
    Maschi C; Thariat J; Herault J; Caujolle JP
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):198-203. PubMed ID: 26385821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam therapy for the treatment of uveal melanoma in Scotland.
    Macdonald EC; Cauchi P; Kemp EG
    Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
    Verma V; Mehta MP
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early ultrasonographic tumor regression after linear accelerator stereotactic fractionated photon radiotherapy of choroidal melanoma as a predictor for metastatic spread.
    Mitsch C; Zehetmayer M; Gleiss A; Georg D; Dieckmann K; Pötter R; Sayegh R; Schmidt-Erfurth U; Dunavoelgyi R
    Radiother Oncol; 2018 Jun; 127(3):385-391. PubMed ID: 29747872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning.
    Lu JE; Welch RJ; Mishra KK; Daftari IK; Park SS
    Eye (Lond); 2019 Dec; 33(12):1904-1910. PubMed ID: 31278380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma.
    Kaiserman I; Anteby I; Chowers I; Blumenthal EZ; Kliers I; Pe'er J
    Br J Ophthalmol; 2004 Jul; 88(7):892-5. PubMed ID: 15205232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of high-frequency ultrasound imaging to improve delineation of anterior uveal melanoma for proton irradiation.
    Daftari I; Barash D; Lin S; O'Brien J
    Phys Med Biol; 2001 Feb; 46(2):579-90. PubMed ID: 11229735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients With Uveal Melanoma Treated With Proton Beam Therapy.
    Lee HJ; Stacey A; Klesert TR; Wells C; Skalet AH; Bloch C; Fung A; Bowen SR; Wong TP; Shibata D; Halasz LM; Rengan R
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):374-382. PubMed ID: 30763658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour regression of uveal melanoma after ruthenium-106 brachytherapy or stereotactic radiotherapy with gamma knife or linear accelerator.
    Georgopoulos M; Zehetmayer M; Ruhswurm I; Toma-Bstaendig S; Ségur-Eltz N; Sacu S; Menapace R
    Ophthalmologica; 2003; 217(5):315-9. PubMed ID: 12913319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
    Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study.
    Kaliki S; Shields CL; Rojanaporn D; Badal J; Devisetty L; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 May; 120(5):1004-11. PubMed ID: 23347983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients.
    Desjardins L; Lumbroso-Le Rouic L; Levy-Gabriel C; Dendale R; Delacroix S; Nauraye C; Estève M; Plancher C; Asselain B
    Ophthalmic Res; 2006; 38(5):255-60. PubMed ID: 16888407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
    Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
    Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
    Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton beam radiotherapy for choroidal and ciliary body melanoma in the UK-national audit of referral patterns of 1084 cases.
    Hussain RN; Chiu A; Pittam B; Taktak A; Damato BE; Kacperek A; Errington D; Cauchi P; Chadha V; Connolly J; Salvi S; Rundle P; Cohen V; Arora A; Sagoo M; Bekir O; Kopsidas K; Heimann H
    Eye (Lond); 2023 Apr; 37(5):1033-1036. PubMed ID: 35840716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
    Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
    Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.